Skip to content
Surgery for Early-Stage NSCLC
Adjuvant/Neo-adjuvant Systemic Therapy
Radiation in Early-Stage NSCLC
Locally Advanced NSCLC- Radiation Therapy
Stage III NSCLC – Surgical/Combined Modality
Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy
Palliative Care Approaches in Lung Cancer
Tumor Biology, Pathology, Novel Diagnostics
ALK, ROS1, and BRAF Positive Lung Cancer
EGFR Mutated Lung Cancer - Advanced Stage
Other Oncogene-Driven Cancers
PD-1/PD-L1 Directed Immunotherapy for Advanced NSCLC
Other Immunotherapy Targets & Agents- Advanced NSCLC
Mesothelioma and Thymoma – Limited and Advanced Stage
Pharmacology I: What HemOnc Clinicians Must Know in Immunotherapy
Cancer Genetic Risk Factors: What’s New and What You Need to Know?
Neuro-Oncology: Novel Advances in Therapy
Kidney Cancer: Novel Development in Targeted and Immunotherapy
Bladder Cancer: Novel Insights and Recent Approvals
Testicular Cancer: The Old, The New, The Future
Prostate Cancer: Early and Locally Advanced Disease
Metastatic Castration Resistant Prostate Cancer: Sequencing the Treatment
Cost and Access to Novel Therapeutic Agents? Where Are The Obstacles?
Equity and Equality for Minorities in Cancer Care
Post navigation
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok 
